(XEMD) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000GWA2J58 • Global Emerging Markets Equity
XEMD: Stocks, Bonds, Emerging Markets, Securities
Xtrackers MSCI Emerging Markets UCITS ETF 1D (XETRA:XEMD) is a Ireland-domiciled ETF designed for investors seeking exposure to emerging markets equities. Listed on the XETRA exchange, this fund tracks the Morningstar EM Total Return Net USD Index, offering a diversified portfolio of stocks across various emerging economies.
With an AUM of 5.417 billion EUR, this ETF is a sizable fund, indicating strong investor interest and liquidity. Its expense ratio is competitive, making it a cost-effective option for those looking to gain broad exposure to emerging markets without the need for direct stock selection.
As a UCITS-compliant ETF, it adheres to strict European regulations, providing investors with a level of transparency and regulatory security. This structure is particularly appealing to institutional investors and fund managers who prioritize compliance and stability in their portfolios.
The funds focus on emerging markets positions it as a vehicle for growth, given the long-term potential of these economies. However, it also comes with higher volatility and risks associated with geopolitical and economic uncertainties in these regions.
For fund managers and investors, this ETF offers the benefits of diversification, liquidity, and a rules-based approach to tracking its underlying index. It is a practical tool for those looking to allocate a portion of their portfolio to emerging markets while managing costs and operational complexity.
Additional Sources for XEMD ETF
XEMD ETF Overview
Market Cap in USD | 5,870m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2021-11-03 |
XEMD ETF Ratings
Growth 5y | 23.7% |
Fundamental | - |
Dividend | 47.3% |
Rel. Strength Industry | -13.4 |
Analysts | - |
Fair Price Momentum | 6.71 EUR |
Fair Price DCF | - |
XEMD Dividends
Dividend Yield 12m | 2.28% |
Yield on Cost 5y | 2.28% |
Annual Growth 5y | 8.74% |
Payout Consistency | 96.9% |
XEMD Growth Ratios
Growth Correlation 3m | 25% |
Growth Correlation 12m | 81% |
Growth Correlation 5y | 32% |
CAGR 5y | 0.24% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | 0.94 |
Alpha | 2.34 |
Beta | 0.65 |
Volatility | 16.85% |
Current Volume | 32.2k |
Average Volume 20d | 10.5k |
As of March 14, 2025, the stock is trading at EUR 7.17 with a total of 32,176 shares traded.
Over the past week, the price has changed by -1.40%, over one month by -4.18%, over three months by -2.78% and over the past year by +8.80%.
Neither. Based on ValueRay Analyses, Xtrackers MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.65 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XEMD as of March 2025 is 6.71. This means that XEMD is currently overvalued and has a potential downside of -6.42%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, XEMD Xtrackers MSCI Emerging will be worth about 7.4 in March 2026. The stock is currently trading at 7.17. This means that the stock has a potential upside of +3.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.4 | 3.8% |